SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

TUNSTALL GORDON

(Last)

(First)

(Middle)

228 STRAWBRIDGE DRIVE, SUITE 100

(Street)

MOORESTOWN

08057

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/28/2016

3. Issuer Name and Ticker or Trading Symbol
Tabula Rasa HealthCare, Inc. [ TRHC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock⁽¹⁾	5,565	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽²⁾	03/21/2022	Common Stock	77,319	$1.55	D
Stock Option (right to buy)	⁽³⁾	11/19/2023	Common Stock	25,773	$3.58	D
Stock Option (right to buy)	⁽⁴⁾	01/01/2025	Common Stock	33,504	$5.82	D

Explanation of Responses:

1. Mr. Tunstall received a restricted stock award of 3,710 shares of the Company's common stock on September 28, 2016. One-third of the restrictions on the restricted stock will lapse on each of the first, second and third anniversary of the grant date. Mr. Tunstall also received a restricted stock award of 1,855 shares of the Company's common stock on September 28, 2016. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant.

2. The Stock Option vests 25% on March 21, 2013 and in equal 1/36th installments each month thereafter.

3. The Stock Option vests 25% on November 19, 2014 and in equal 1/36th installments each month thereafter.

4. The Stock Option vests 25% on January 1, 2016 and in equal 1/36th installments each month thereafter.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Brian W. Adams, attorney-in-fact	09/28/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.